Xenetic Biosciences(XBIO)
FRAMINGHAM, MABiotechnology
Focus: Xenetic Biosciences is a public micro-cap biotech focused on biologic drugs for oncology and vaccines, currently with minimal revenue ($3M) and a lean clinical pipeline.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Xenetic Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow Xenetic Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Xenetic Biosciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$3M
FY2025
Pipeline & Clinical Trials
Sodium Cridanimod
Endometrial CancerClinical Trials (1)
NCT03077698An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Phase 2Help build intelligence for Xenetic Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.